ID   R3HD1_HUMAN             Reviewed;        1099 AA.
AC   Q15032; A8K1V0; B3KXQ9; E9PBB4; E9PG42; G5E9G8; Q8IW32;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   07-APR-2021, entry version 161.
DE   RecName: Full=R3H domain-containing protein 1;
GN   Name=R3HDM1; Synonyms=KIAA0029, R3HDM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND VARIANT
RP   PRO-632.
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT VAL-270.
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-973, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-187 AND SER-381, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-187; SER-262; SER-302;
RP   SER-381; SER-393 AND SER-973, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-929, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- INTERACTION:
CC       Q15032-2; P54253: ATXN1; NbExp=3; IntAct=EBI-10966812, EBI-930964;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q15032-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15032-2; Sequence=VSP_017344, VSP_017345, VSP_054310;
CC       Name=3;
CC         IsoId=Q15032-3; Sequence=VSP_054310;
CC       Name=4;
CC         IsoId=Q15032-4; Sequence=VSP_054308, VSP_054309, VSP_054310;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA04878.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D21852; BAA04878.2; ALT_INIT; mRNA.
DR   EMBL; AK127793; BAG54571.1; -; mRNA.
DR   EMBL; AK290015; BAF82704.1; -; mRNA.
DR   EMBL; AC011893; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016742; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11627.1; -; Genomic_DNA.
DR   EMBL; BC041093; AAH41093.1; -; mRNA.
DR   CCDS; CCDS2177.1; -. [Q15032-1]
DR   CCDS; CCDS63024.1; -. [Q15032-4]
DR   CCDS; CCDS63025.1; -. [Q15032-3]
DR   CCDS; CCDS63026.1; -. [Q15032-2]
DR   RefSeq; NP_001269727.1; NM_001282798.1. [Q15032-3]
DR   RefSeq; NP_001269728.1; NM_001282799.1. [Q15032-2]
DR   RefSeq; NP_001269729.1; NM_001282800.1. [Q15032-4]
DR   RefSeq; NP_056176.2; NM_015361.3. [Q15032-1]
DR   RefSeq; XP_006712452.1; XM_006712389.2.
DR   RefSeq; XP_016859207.1; XM_017003718.1.
DR   SMR; Q15032; -.
DR   BioGRID; 117065; 64.
DR   IntAct; Q15032; 17.
DR   MINT; Q15032; -.
DR   STRING; 9606.ENSP00000387010; -.
DR   GlyGen; Q15032; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q15032; -.
DR   PhosphoSitePlus; Q15032; -.
DR   BioMuta; R3HDM1; -.
DR   DMDM; 92086999; -.
DR   EPD; Q15032; -.
DR   jPOST; Q15032; -.
DR   MassIVE; Q15032; -.
DR   MaxQB; Q15032; -.
DR   PaxDb; Q15032; -.
DR   PeptideAtlas; Q15032; -.
DR   PRIDE; Q15032; -.
DR   ProteomicsDB; 19186; -.
DR   ProteomicsDB; 20240; -.
DR   ProteomicsDB; 33934; -.
DR   ProteomicsDB; 60381; -. [Q15032-1]
DR   ProteomicsDB; 60382; -. [Q15032-2]
DR   Antibodypedia; 51003; 11 antibodies.
DR   Ensembl; ENST00000264160; ENSP00000264160; ENSG00000048991. [Q15032-1]
DR   Ensembl; ENST00000409478; ENSP00000386457; ENSG00000048991. [Q15032-2]
DR   Ensembl; ENST00000409606; ENSP00000387010; ENSG00000048991. [Q15032-3]
DR   Ensembl; ENST00000410054; ENSP00000386877; ENSG00000048991. [Q15032-4]
DR   Ensembl; ENST00000628915; ENSP00000486837; ENSG00000048991. [Q15032-2]
DR   GeneID; 23518; -.
DR   KEGG; hsa:23518; -.
DR   UCSC; uc002tuo.5; human. [Q15032-1]
DR   CTD; 23518; -.
DR   DisGeNET; 23518; -.
DR   GeneCards; R3HDM1; -.
DR   HGNC; HGNC:9757; R3HDM1.
DR   HPA; ENSG00000048991; Tissue enhanced (brain).
DR   neXtProt; NX_Q15032; -.
DR   OpenTargets; ENSG00000048991; -.
DR   PharmGKB; PA34098; -.
DR   VEuPathDB; HostDB:ENSG00000048991.16; -.
DR   eggNOG; KOG2953; Eukaryota.
DR   GeneTree; ENSGT00940000156095; -.
DR   HOGENOM; CLU_007817_0_0_1; -.
DR   InParanoid; Q15032; -.
DR   OMA; GHQCAAV; -.
DR   OrthoDB; 137913at2759; -.
DR   PhylomeDB; Q15032; -.
DR   TreeFam; TF315915; -.
DR   PathwayCommons; Q15032; -.
DR   BioGRID-ORCS; 23518; 7 hits in 995 CRISPR screens.
DR   ChiTaRS; R3HDM1; human.
DR   GenomeRNAi; 23518; -.
DR   Pharos; Q15032; Tdark.
DR   PRO; PR:Q15032; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q15032; protein.
DR   Bgee; ENSG00000048991; Expressed in corpus callosum and 249 other tissues.
DR   ExpressionAtlas; Q15032; baseline and differential.
DR   Genevisible; Q15032; HS.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   Gene3D; 3.30.1370.50; -; 1.
DR   InterPro; IPR001374; R3H_dom.
DR   InterPro; IPR036867; R3H_dom_sf.
DR   InterPro; IPR024771; SUZ.
DR   Pfam; PF01424; R3H; 1.
DR   Pfam; PF12752; SUZ; 1.
DR   SMART; SM00393; R3H; 1.
DR   SUPFAM; SSF82708; SSF82708; 1.
DR   PROSITE; PS51061; R3H; 1.
DR   PROSITE; PS51673; SUZ; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Methylation; Phosphoprotein; Reference proteome.
FT   CHAIN           1..1099
FT                   /note="R3H domain-containing protein 1"
FT                   /id="PRO_0000097139"
FT   DOMAIN          168..231
FT                   /note="R3H"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00382"
FT   DOMAIN          232..302
FT                   /note="SUZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01009"
FT   COMPBIAS        89..94
FT                   /note="Poly-Pro"
FT   COMPBIAS        589..608
FT                   /note="Poly-Pro"
FT   COMPBIAS        822..826
FT                   /note="Poly-Pro"
FT   MOD_RES         187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         381
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         929
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         929
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         973
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..44
FT                   /note="MRMSDTVTVKDETATMKDLEAEVKDTTRVENLIKSENYGKILVE -> MGLL
FT                   LPDYRWFTTVDILADNCEKEPWIILFYFCGTPQSQIQRTH (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054308"
FT   VAR_SEQ         45..100
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054309"
FT   VAR_SEQ         57..100
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7584026"
FT                   /id="VSP_017344"
FT   VAR_SEQ         406..490
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7584026"
FT                   /id="VSP_017345"
FT   VAR_SEQ         541
FT                   /note="Q -> QQ (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7584026"
FT                   /id="VSP_054310"
FT   VARIANT         270
FT                   /note="M -> V (in dbSNP:rs961360)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_025423"
FT   VARIANT         632
FT                   /note="Q -> P (in dbSNP:rs2305165)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_025424"
FT   CONFLICT        125
FT                   /note="K -> E (in Ref. 2; BAF82704)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        902
FT                   /note="K -> R (in Ref. 2; BAF82704)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1075
FT                   /note="S -> L (in Ref. 2; BAF82704)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1099 AA;  120696 MW;  67782B9163702174 CRC64;
     MRMSDTVTVK DETATMKDLE AEVKDTTRVE NLIKSENYGK ILVEKNEHCI ENNIDLQRPL
     QSFGQTGKRS KSSSKLKLVR SLAVCEESPP PPAPEISQEN QEKIQIQLTQ SFEKEEKPSK
     DEAEKEKASD KLPRKMLSRD SSQEYTDSTG IDLHEFLVNT LKNNPRDRMM LLKLEQEILD
     FIGNNESPRK KFPPMTSYHR MLLHRVAAYF GLDHNVDQSG KSVIVNKTSN TRIPDQKFNE
     HIKDDKGEDF QKRYILKRDN SSFDKDDNQM RIRLKDDRRS KSIEEREEEY QRARDRIFSQ
     DSLCSQENYI IDKRLQDEDA SSTQQRRQIF RVNKDASGRS TNSHQSSTEN ELKYSEPRPW
     SSTDSDSSLR NLKPAVTKAS SFSGISVLTR GDSSGSSKSI GRLSKTGSES SGSVGSSTGS
     LSHIQQPLPG TALSQSSHGA PVVYPTVSTH SSLSFDGGLN GQVASPSTSF FLLPLEAAGI
     PPGSILINPQ TGQPFINPDG SPVVYNPPMT QQPVRSQVPG PPQPPLPAPP QQPAANHIFS
     QDNLGSQFSH MSLARQPSAD GSDPHAAMFQ STVVLQSPQQ SGYIMTAAPP PHPPPPPPPP
     PPPPPLPPGQ PVPTAGYPAS GHPVSQPVLQ QQGYIQQPSP QMPACYCAPG HYHSSQPQYR
     PVPSVHYNSH LNQPLPQPAQ QTGYQVIPNQ QQNYQGIVGV QQPQSQSLVS GQPNSIGNQI
     QGVVIPYTSV PTYQVSLPQG SQGIPHQTYQ QPVMFPNQSN QGSMPTTGMP VYYSVIPPGQ
     QNNLSSSVGY LQHPGSEQVQ FPRTTSPCSS QQLQGHQCTA GPPPPPGGGM VMMQLSVPNN
     PQSCAHSPPQ WKQNKYYCDH QRGQKCVEFS SVDNIVQHSP QLSSPIISPA QSPAPAQLST
     LKTVRPSGPP LSIMPQFSRP FVPGQGDSRY PLLGQPLQYN PPAVLHGHIP NQQGQPGSRH
     GNRGRRQAKK AASTDLGAGE TVVGKVLEIT ELPDGITRME AEKLFGELFK IGAKIRWLRD
     PQSQPRRHPL CCGSGDNTAN PERSKPSDLA STYTVLATFP SISAAQNALK KQINSVNKFK
     LRTSKKHYDF HILERASSQ
//
